Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis

Published:2023-12 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Gomez-Veiga Francisco,Szmulewitz Russell Z.,Holzbeierlein Jeffrey,Azad Arun A.,Iguchi Taro,Villers Arnauld,Alcaraz Antonio,Alekseev Boris,Shore Neal D.,Rosbrook Brad,Zohren Fabian,Ma Jie,Haas Gabriel P.,Stenzl Arnulf,Armstrong Andrew J.

Funder

Pfizer Inc

Astellas Pharma

Pfizer

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference30 articles.

1. Impact of age at diagnosis on outcomes in men with castrate-resistant prostate cancer (CRPC);Humphreys;J Cancer,2013

2. Prostate cancer in the elderly;Scosyrev;Cancer,2012

3. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience;DiBlasio;BJU Int,2009

4. National Cancer Institute. Cancer stat facts: prostate cancer. 2021. https://seer.cancer.gov/statfacts/html/prost.html.

5. Impact of age at diagnosis of de novo metastatic prostate cancer on survival;Bernard;Cancer,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic Prostate Cancer: Sequential or Combination Therapy?;Clinical Genitourinary Cancer;2024-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP